<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0810">
 <label>162</label>
 <element-citation publication-type="journal" id="h0810">
  <person-group person-group-type="author">
   <name>
    <surname>Choy</surname>
    <given-names>K.T.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>A.Y.L.</given-names>
   </name>
   <name>
    <surname>Kaewpreedee</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Sia</surname>
    <given-names>S.F.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hui</surname>
    <given-names>K.P.Y.</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>D.K.W.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>M.C.W.</given-names>
   </name>
   <name>
    <surname>Cheung</surname>
    <given-names>P.P.H.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Peiris</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yen</surname>
    <given-names>H.L.</given-names>
   </name>
  </person-group>
  <article-title>Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro</article-title>
  <source>Antiviral Res.</source>
  <volume>178</volume>
  <year>2020</year>
  <object-id pub-id-type="publisher-id">104786</object-id>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104786</pub-id>
 </element-citation>
</ref>
